David Peace

Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043

Nature Communications 2024cited by 8position: middledoi

Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)

Journal for ImmunoTherapy of Cancer 2023cited by 30position: middledoi

Impact of initial chemotherapy regimen on outcomes for patients with double‐expressor lymphoma: A multi‐center analysis

Hematological Oncology 2021cited by 12position: middledoi

Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Journal of Clinical Oncology 2020cited by 150position: middledoi

Phase II study of nivolumab and salvage nivolumab + ipilimumab in treatment-naïve patients (pts) with advanced renal cell carcinoma (RCC) (HCRN GU16-260).

Journal of Clinical Oncology 2020cited by 56position: middledoi

Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics

Blood Advances 2020cited by 43position: middledoi

Haploidentical Peripheral Blood Stem Cell Transplantation Demonstrates Stable Engraftment in Adults with Sickle Cell Disease

Biology of Blood and Marrow Transplantation 2018cited by 63position: middledoi

A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m<sup>2</sup>and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma

Leukemia & lymphoma/Leukemia and lymphoma 2017cited by 24position: middledoi

Synuclein‐γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study

Cancer 2016cited by 18position: middledoi

Outcome Disparities in Caucasian and Non-Caucasian Patients With Myeloproliferative Neoplasms

Clinical Lymphoma Myeloma & Leukemia 2016cited by 18position: middledoi

Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease

Biology of Blood and Marrow Transplantation 2015cited by 144position: middledoi

The transcription factor Foxm1 is essential for the quiescence and maintenance of hematopoietic stem cells

Nature Immunology 2015cited by 76position: middledoi

Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis

Blood 2014cited by 464position: middledoi

Combination of Linear Accelerator–Based Intensity-Modulated Total Marrow Irradiation and Myeloablative Fludarabine/Busulfan: A Phase I Study

Biology of Blood and Marrow Transplantation 2014cited by 49position: middledoi

FHL2 regulates hematopoietic stem cell functions under stress conditions

Leukemia 2014cited by 31position: middledoi

Feasibility of Implementing a Comprehensive Warfarin Pharmacogenetics Service

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy 2013cited by 82position: middledoi

Impact Of Induction Regimen and Consolidative Stem Cell Transplantation In Patients With Double Hit Lymphoma (DHL): A Large Multicenter Retrospective Analysis

Blood 2013cited by 14position: middledoi

Recent publications

Grants

Frequent collaborators